Incidence of mortality due to rebound toxicity after 'treat and release' practices in prehospital opioid overdose care: a systematic review.
Emergency Medicine Journal · 2018-12-22 · Systematic review
Abstract
INTRODUCTION: Death due to opioid overdose was declared a public health crisis in Canada in 2015. Traditionally, patients who have overdosed on opioids that are managed by emergency medical services (EMS) are treated with the opioid antagonist naloxone, provided ventilatory support and subsequently transported to hospital. However, certain EMS agencies have permitted patients who have been reversed from opioid overdose to refuse transport, if the patient exhibits capacity to do so. Evidence on the safety of this practice is limited. Therefore, our intent was to examine the available literature to determine mortality and serious adverse events within 48 hours of EMS treat and release due to suspected rebound opioid toxicity after naloxone administration. METHODS: A systematic search was performed on 11 May 2017 in PubMed, Cochrane Central, Embase and CINHAL. Studies that reported on the outcome of patients treated with prehospital naloxone and released at the scene were included. Analyses for incidence of mortality and adverse events at the scene were conducted. Risk of bias and assessment of publication bias was also done. RESULTS: 1401 records were screened after duplicate removal. Eighteen full-text studies were reviewed with seven selected for inclusion. None were found to be high risk of bias. In most studies, heroin was the source of the overdose. Mortality within 48 hours was infrequent with only four deaths among 4912 patients ﴾0.081%﴿ in the seven studies. Only one study reported on adverse events and found no incidence of adverse events from their sample of 71 released patients. CONCLUSION: Mortality or serious adverse events due to suspected rebound toxicity in patients released on scene post-EMS treatment with naloxone were rare. However, studies involving longer-acting opioids were rare and no study involved fentanyl.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antidotes · Heroin · Mortality & survival · Naloxone · Poisoning & substance use
Related articles
- Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment. (Clin Toxicol (Phila), 2018)
- Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. (Acad Emerg Med, 2003)
- The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews. (Am J Public Health, 2021)
- Do heroin overdose patients require observation after receiving naloxone? (Clin Toxicol (Phila), 2017)
- Opioid Epidemic Through the Lens of Prehospital Emergency Care: A 5-Year Descriptive Analysis of the Statewide Opioid Response Directive (SWORD) Surveillance Program. (Prehosp Emerg Care, 2025)
- Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial. (J Urban Health, 2013)